News

Researchers have developed a miniaturized platform for screening 3D tumor models to evaluate the toxicity of CAR-T therapy towards cells.

MIT researchers have built a new computer model that can rapidly scan the entire genome of cancer cells and identify mutations that occur more frequently than expected, suggesting that they are driving tumor growth.

Researchers report that two proteins, YAP and TAZ, play a crucial role in blood vessel growth, even under challenging metabolic conditions.

A new drug screening method has been used to identify an effective drug combination to treat acute lymphoblastic leukemia, the most common cancer affecting children.

Researchers have identified the mechanism by which active inflammation occurs in parallel with immunosuppression in the tumor microenvironment.

Researchers have developed a nanophotonic-microfluidic sensor that has potential applications in cancer detection, monitoring and treatment response assessment.

According to research, the accuracy of diagnostic mammograms differed across racial and ethnic groups, with variation in several measures of diagnostic performance.

Researchers have developed a liquid biopsy that can effectively determine if a patient with esophageal cancer will respond to certain treatments, potentially avoiding patients receiving unnecessary additional therapy.

A new study finds that a unique combination drug strategy could activate natural killer cells to reinvigorate T cells to attack melanoma tumors.

Researchers have conducted one of the largest investigations to date studying the associations between a person's height and their risk of disease. The results show, whether tall or short, that height is a plausible risk factor for many conditions.